EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 1 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $40,000 | – | 66,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 133,332 | $39,733 | 0.09% |
| ANGELO GORDON & CO., L.P. | 13,333 | $134,663 | 0.02% |
| Radcliffe Capital Management, L.P. | 66,566 | $672,317 | 0.02% |
| Dryden Capital, LLC | 15,000 | $4,470 | 0.01% |
| METEORA CAPITAL, LLC | 50,000 | $14,900 | 0.00% |
| Arena Capital Advisors, LLC- CA | 19,251 | $5,737 | 0.00% |
| MMCAP International Inc. SPC | 73,525 | $21,910 | 0.00% |
| PERISCOPE CAPITAL INC. | 196,896 | $57,571 | 0.00% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 21,896 | $6,525 | 0.00% |
| CLEAR STREET LLC | 217,000 | $65 | 0.00% |